New regenerative treatments are on the horizon—can they deliver? The clinical landscape today is being reshaped by a host of biomedical innovations, some of which will make their way to the clinic. One area attracting major interest is that of regenerative medicine, where live cells and tissues are used to treat disease with new, healthy, and specially grown tissue. The belief is that regenerative medicine will provide much needed therapeutic options for patients with conditions such as retinitis pigmentosa and age related macular degeneration.12 Regenerative treatments are often compared to monoclonal antibodies in terms of their potential for clinical and economic benefits.3 Many governments see the field as potentially revolutionary, including those in Australia, Japan, the UK, and the US.4 Commercial investment is also increasing rapidly, although no products are yet widely available on the market. Commissioning new therapies is under increasing budgetary pressure, however, with little spare cash available for innovation, especially in the NHS. A recent House of Commons inquiry called for new incentives to stimulate development and adoption of …

中文翻译：

---

再生药

新的再生疗法即将出现，它们能带来效果吗？许多生物医学创新正在改变当今的临床格局，其中一些将进入临床。再生医学领域是引起人们极大兴趣的领域，在再生医学领域，活细胞和组织被用于治疗新的，健康的和特别生长的组织的疾病。人们相信，再生医学将为患有色素性视网膜炎和与年龄相关的黄斑变性等疾病的患者提供急需的治疗选择。12就其在临床和经济方面的潜力而言，再生疗法经常与单克隆抗体进行比较。3许多政府认为该领域具有潜在的革命性，包括澳大利亚，日本，英国和美国。4商业投资也在迅速增长，尽管目前市场上还没有广泛可用的产品。但是，调试新疗法的预算压力越来越大，尤其是在NHS中，用于创新的可用现金很少。下议院最近的一项调查要求采取新的激励措施，以刺激……的发展和采用……